ProCE Banner Activity

Pulling Back the Curtain: The Importance of Staging Fibrosis in Patients With Chronic Hepatitis B

Clinical Thought

For patients with chronic hepatitis B, accurate liver fibrosis staging is key for risk stratification and designing management strategies. Read my commentary on the available noninvasive tests for assessing liver fibrosis and learn what methods may best suit your patients.

Released: January 12, 2024

Share

Faculty

Grace LH Wong

Grace LH Wong, MD

Professor
Division of Gastroenterology and Hepatology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
Honorary Consultant
Division of Gastroenterology and Hepatology
Department of Medicine and Therapeutics
Prince of Wales Hospital
Hong Kong

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Grace LH Wong, MD

Professor
Division of Gastroenterology and Hepatology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
Honorary Consultant
Division of Gastroenterology and Hepatology
Department of Medicine and Therapeutics
Prince of Wales Hospital
Hong Kong

Grace LH Wong, MD: consultant: Gilead Sciences, GSK, Janssen; researcher: Abbvie, Gilead Sciences; non-CME/CE services: Abbott, Abbvie, Bristol Myers Squibb, Echosens, Furui, Gilead Sciences, Janssen, Roche.